Zymeworks Inc (ZYME) is around the top of the Biotechnology industry according to InvestorsObserver. ZYME received an overall rating of 60, which means that it scores higher than 60 percent of all stocks. Zymeworks Inc also achieved a score of 75 in the Biotechnology industry, putting it above 75 percent of Biotechnology stocks. Biotechnology is ranked 54 out of the 148 industries.
ZYME has an Overall Score of 60. Find out what this means to you and get the rest of the rankings on ZYME!
Trying to find the best stocks can be a daunting task. There are a wide variety of ways to analyze stocks in order to determine which ones are performing the strongest. InvestorsObserver makes the entire process easier by using percentile rankings that allows you to easily find the stocks who have the strongest evaluations by analysts.
This ranking system incorporates numerous factors used by analysts to compare stocks in greater detail. This allows you to find the best stocks available in any industry with relative ease. These percentile-ranked scores using both fundamental and technical analysis give investors an easy way to view the attractiveness of specific stocks. Stocks with the highest scores have the best evaluations by analysts working on Wall Street.
What's Happening With Zymeworks Inc Stock Today?
Zymeworks Inc (ZYME) stock is higher by 0.26% while the S&P 500 has fallen -1.65% as of 3:21 PM on Monday, Nov 28. ZYME has risen $0.02 from the previous closing price of $7.84 on volume of 391,678 shares. Over the past year the S&P 500 is lower by -14.94% while ZYME has fallen -59.44%. ZYME lost -$3.63 per share the over the last 12 months.
Click Here to get the full Stock Report for Zymeworks Inc stock.
Share this article:
Stay In The Know
Subscribe to our daily morning update newsletter and never miss out on the need-to-know market news, movements, and more.
Thank you for signing up! You're all set to receive the Morning Update newsletter
